ZIM Laboratories Limited (ZIMLAB.BO)
INR 91.74
(-0.1%)
INR 91.74
(-0.1%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.67 Billion INR | -6.8% |
| 2022 | 3.94 Billion INR | 19.21% |
| 2021 | 3.3 Billion INR | 12.3% |
| 2020 | 2.94 Billion INR | 12.61% |
| 2019 | 2.61 Billion INR | -19.93% |
| 2018 | 3.26 Billion INR | 22.39% |
| 2017 | 2.66 Billion INR | 16.2% |
| 2016 | 2.29 Billion INR | -13.0% |
| 2015 | 2.63 Billion INR | 0.82% |
| 2014 | 2.61 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 818.24 Million INR | -30.58% |
| 2023 Q2 | 858.26 Million INR | 27.26% |
| 2023 FY | 3.67 Billion INR | -6.8% |
| 2023 Q1 | 674.42 Million INR | -33.31% |
| 2023 Q3 | 962.92 Million INR | 12.2% |
| 2023 Q4 | 1.17 Billion INR | 22.4% |
| 2022 Q4 | 1.01 Billion INR | 0.16% |
| 2022 Q1 | 927.45 Million INR | -9.34% |
| 2022 Q2 | 994 Million INR | 7.18% |
| 2022 FY | 3.94 Billion INR | 19.21% |
| 2022 Q3 | 1 Billion INR | 1.58% |
| 2021 Q4 | 1.02 Billion INR | 17.97% |
| 2021 FY | 3.3 Billion INR | 12.3% |
| 2021 Q1 | 641.72 Million INR | 5.04% |
| 2021 Q3 | 867.16 Million INR | 11.93% |
| 2021 Q2 | 774.73 Million INR | 20.73% |
| 2020 Q2 | 880.33 Million INR | 24.91% |
| 2020 Q3 | 749.06 Million INR | -14.91% |
| 2020 FY | 2.94 Billion INR | 12.61% |
| 2020 Q4 | 610.95 Million INR | -18.44% |
| 2020 Q1 | 704.75 Million INR | 33.03% |
| 2019 Q1 | 674.07 Million INR | -21.45% |
| 2019 Q2 | 677.9 Million INR | 0.57% |
| 2019 FY | 2.61 Billion INR | -19.93% |
| 2019 Q4 | 529.79 Million INR | -27.77% |
| 2019 Q3 | 733.45 Million INR | 8.19% |
| 2018 Q4 | 858.15 Million INR | -12.48% |
| 2018 Q2 | 716.74 Million INR | 0.87% |
| 2018 Q1 | 710.54 Million INR | 8.4% |
| 2018 FY | 3.26 Billion INR | 22.39% |
| 2018 Q3 | 980.53 Million INR | 36.8% |
| 2017 Q4 | 655.46 Million INR | -12.71% |
| 2017 Q3 | 750.88 Million INR | 19.52% |
| 2017 Q1 | 634.73 Million INR | 0.0% |
| 2017 Q2 | 628.23 Million INR | -1.02% |
| 2017 FY | 2.66 Billion INR | 16.2% |
| 2016 FY | 2.29 Billion INR | -13.0% |
| 2015 FY | 2.63 Billion INR | 0.82% |
| 2014 FY | 2.61 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Eris Lifesciences Limited | 20.09 Billion INR | 81.712% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 96.89% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -252.158% |
| Medico Remedies Limited | 1.44 Billion INR | -153.535% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | 71.315% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -386.363% |
| Wanbury Limited | 5.75 Billion INR | 36.172% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | 71.639% |
| Mankind Pharma Limited | 103.34 Billion INR | 96.445% |
| Alkem Laboratories Limited | 126.67 Billion INR | 97.099% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 98.72% |
| Bajaj HealthCare Limited | 4.73 Billion INR | 22.389% |
| Sigachi Industries Limited | 3.98 Billion INR | 7.904% |
| Achyut Healthcare Limited | 61.36 Million INR | -5887.134% |
| Ajanta Pharma Limited | 42.08 Billion INR | 91.27% |
| Alpa Laboratories Limited | 1.08 Billion INR | -237.896% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 93.989% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 98.684% |
| FDC Limited | 19.42 Billion INR | 81.089% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | 52.298% |
| Granules India Limited | 45.06 Billion INR | 91.847% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 83.908% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -76.052% |
| Laurus Labs Limited | 50.01 Billion INR | 92.654% |
| Lupin Limited | 200.1 Billion INR | 98.164% |
| Megasoft Limited | 373.95 Million INR | -882.542% |
| Procter & Gamble Health Limited | 11.51 Billion INR | 68.085% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 99.242% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | 65.052% |
| Piramal Pharma Limited | 81.71 Billion INR | 95.503% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -41.729% |
| Unichem Laboratories Limited | 16.57 Billion INR | 77.831% |
| Windlas Biotech Limited | 6.3 Billion INR | 41.767% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 98.068% |
| Brooks Laboratories Limited | 794.86 Million INR | -362.25% |
| Divi's Laboratories Limited | 78.45 Billion INR | 95.316% |
| Gufic Biosciences Limited | 8.06 Billion INR | 54.451% |
| Hester Biosciences Limited | 3.04 Billion INR | -20.647% |
| Indoco Remedies Limited | 17.89 Billion INR | 79.467% |
| Ipca Laboratories Limited | 76.22 Billion INR | 95.18% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -628.706% |
| Medicamen Biotech Limited | 1.79 Billion INR | -104.914% |
| NATCO Pharma Limited | 40.02 Billion INR | 90.819% |
| RPG Life Sciences Limited | 5.82 Billion INR | 36.874% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | 12.774% |
| Bal Pharma Limited | 3.39 Billion INR | -8.315% |
| Strides Pharma Science Limited | 40.51 Billion INR | 90.93% |
| Venus Remedies Limited | 5.91 Billion INR | 37.877% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | 79.762% |
| Nectar Lifesciences Limited | 16.84 Billion INR | 78.183% |
| Shilpa Medicare Limited | 11.51 Billion INR | 68.095% |
| Aarti Drugs Limited | 25.28 Billion INR | 85.469% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | 82.66% |
| Suven Life Sciences Limited | 116.92 Million INR | -3042.286% |
| Ind-Swift Limited | 5.02 Billion INR | 26.876% |
| Valiant Laboratories Limited | 1.82 Billion INR | -101.818% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | 89.455% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | 70.33% |
| Themis Medicare Limited | 3.81 Billion INR | 3.755% |
| Hikal Limited | 17.84 Billion INR | 79.411% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 96.536% |
| Sequent Scientific Limited | 13.69 Billion INR | 73.175% |
| Novartis India Limited | 3.35 Billion INR | -9.656% |
| Wockhardt Limited | 27.89 Billion INR | 86.826% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 94.518% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -817.751% |
| Neuland Laboratories Limited | 15.58 Billion INR | 76.426% |
| Morepen Laboratories Limited | 17.01 Billion INR | 78.411% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -138.012% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | 0.318% |